Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.48 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA3 | P07451 | 1/20 | 0.35 |
| ▸ | CA4 | P22748 | 1/20 | 0.35 |
| ▸ | CA6 | P23280 | 1/20 | 0.35 |
| ▸ | CA5A | P35218 | 1/20 | 0.35 |
| ▸ | CA7 | P43166 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.35 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4672998 | 1.00 | ALDH1A1 (0.50) | ALDH1A1TSHRDNM1SIGMAR1CYP1A2 | |
| Bromide SCHEMBL10492652 | 0.97 | DNM1 (0.50) | ALDH1A1TSHRDNM1SIGMAR1CYP1A2 | |
| SCHEMBL14666299 | 0.97 | ALDH1A1 (0.47) | ALDH1A1TSHRDNM1SIGMAR1CYP1A2 | |
| SCHEMBL9123900 | 0.94 | ALDH1A1 (0.50) | ALDH1A1TSHRDNM1SIGMAR1CYP1A2 | |
| SCHEMBL19909604 | 0.94 | ALDH1A1 (0.59) | ALDH1A1TSHRDNM1SIGMAR1CYP1A2 | |
| SCHEMBL18210639 | 0.92 | ALDH1A1 (0.43) | ALDH1A1TSHRDNM1SIGMAR1CYP1A2 | |
| SCHEMBL27995059 | 0.91 | ALDH1A1 (0.65) | ALDH1A1TSHRDNM1SIGMAR1SMN1; SMN2 | |
| SCHEMBL4187855 | 0.91 | ALDH1A1 (0.65) | ALDH1A1TSHRDNM1SIGMAR1SMN1; SMN2 | |
| SCHEMBL235041 | 0.87 | SIGMAR1 (0.42) | ALDH1A1SIGMAR1SLC2A1HTR2AHRH1 | |
| SCHEMBL18185238 | 0.86 | CA12 (0.58) | ALDH1A1TSHRDNM1SIGMAR1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 217 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250115832-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2025-04-10 | — | — | US | claimed |
| EP-4384312-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2024-06-19 | — | — | EP | claimed |
| WO-2023017014-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2023-02-16 | — | — | WO | claimed |
| EP-0858995-B1 | Process for the preparation of N-alkyl carbazoles | CLARIANT GMBH (DE) | 2001-12-12 | — | — | EP | claimed |
| US-5902884-A | REACTING CARBAZOLE OR ALKYL, ALKOXY, NITRO OR HALOGEN SUBSTITUED DERIVATIVE WITH AN ALKYL HALIDE IN AN INERT SOLVENT WITH AN INORGANIC BASE AND DI- OR TRI-, ALKYLAMINE CATALYST; NO AFTERTREATMENT REQUIRED TO REMOVE CATALYST | CLARIANT GMBH (DE) | 1999-05-11 | — | — | US | claimed |
| EP-0858995-A1 | Process for the preparation of N-alkyl carbazoles | Clariant GmbH (DE) | 1998-08-19 | — | — | EP | claimed |
| WO-2026104571-A1 | ELECTROLYTE SOLUTION FOR A BATTERY, USE THEREOF AND BATTERY | Atotech Deutschland GmbH & Co. KG (DE) | 2026-05-21 | — | — | WO | disclosed |
| EP-4746086-A1 | ELECTROLYTE SOLUTION FOR A BATTERY, USE THEREOF AND BATTERY | Atotech Deutschland GmbH & Co. KG (DE) | 2026-05-20 | — | — | EP | disclosed |
| US-20260125584-A1 | TWO-COMPONENT EPOXY ADHESIVE FOR LIQUIFIED NATURAL GAS CONTAINERS | SIKA TECHNOLOGY AG (CH) | 2026-05-07 | — | — | US | disclosed |
| US-20260109848-A1 | CRACK-RESISTANT TWO-COMPONENT EPOXY RESIN COMPOSITION | SIKA TECHNOLOGY AG (CH) | 2026-04-23 | — | — | US | disclosed |
| US-12605327-B2 | Hair cosmetic compositions | L'OREAL (FR) | 2026-04-21 | — | — | US | disclosed |
| US-12551430-B2 | Sulfate-free cleansing compositions comprising PEG/PPG-dimethicones | L'OREAL (FR) | 2026-02-17 | — | — | US | disclosed |
| EP-4688903-A1 | MULTI-COMPONENT EPOXY RESIN COMPOSITION WITH ACCELERATED CURING | Sika Technology AG (CH) | 2026-02-11 | — | — | EP | disclosed |
| US-5902884-A | REACTING CARBAZOLE OR ALKYL, ALKOXY, NITRO OR HALOGEN SUBSTITUED DERIVATIVE WITH AN ALKYL HALIDE IN AN INERT SOLVENT WITH AN INORGANIC BASE AND DI- OR TRI-, ALKYLAMINE CATALYST; NO AFTERTREATMENT REQUIRED TO REMOVE CATALYST | CLARIANT GMBH (DE) | 1999-05-11 | — | — | US | disclosed |
| EP-0902032-A1 | Improved process for the preparation of phosphites | GENERAL ELECTRIC COMPANY (US) | 1999-03-17 | — | — | EP | disclosed |
| EP-0858995-A1 | Process for the preparation of N-alkyl carbazoles | Clariant GmbH (DE) | 1998-08-19 | — | — | EP | disclosed |
| US-4443563-A | Polyurethanes based on 1;4-3:6 dianhydrohexitols | THE DOW CHEMICAL COMPANY (US) | 1984-04-17 | — | — | US | disclosed |
| EP-0001616-B1 | CURABLE EPOXY RESIN COMPOSITIONS | CIBA-GEIGY AG (CH) | 1981-07-22 | — | — | EP | disclosed |
| US-4201854-A | N,N-DIMETHYLALKYLENEDIAMINE DERIVATIVE CURING AGENT | CIBA-GEIGY CORPORATION (US) | 1980-05-06 | — | — | US | disclosed |
| EP-0001616-A2 | Curable epoxy resin compositions | CIBA-GEIGY AG (CH) | 1979-05-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12551430-B2 | Sulfate-free cleansing compositions comprising PEG/PPG-dimethicones | SMURF1, SGMS1, DSG1 | ALDH1A1 3425/4885TSHR 3887/4885DNM1 2185/4885 |
| US-20260109848-A1 | CRACK-RESISTANT TWO-COMPONENT EPOXY RESIN COMPOSITION | ARCN1, KATNAL2, KAT2A | ALDH1A1 1028/4885TSHR 3532/4885DNM1 2636/4885 |
| US-12605327-B2 | Hair cosmetic compositions | DSG1, ALG3, DEGS1 | ALDH1A1 1425/4885TSHR 2711/4885DNM1 3680/4885 |
| US-20260125584-A1 | TWO-COMPONENT EPOXY ADHESIVE FOR LIQUIFIED NATURAL GAS CONTAINERS | PTGER2, SETDB1, ITGA2 | ALDH1A1 695/4885TSHR 4679/4885DNM1 3665/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.